Light-responsive nanomedicine for cancer immunotherapy

Immunotherapy emerged as a paradigm shift in cancer treatments, which can effectively inhibit cancer progression by activating the immune system. Remarkable clinical outcomes have been achieved through recent advances in cancer immunotherapy, including checkpoint blockades, adoptive cellular therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Weirong, Liu, Yuwei, Wang, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326299/
https://www.ncbi.nlm.nih.gov/pubmed/37425044
http://dx.doi.org/10.1016/j.apsb.2023.05.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326299/
https://www.ncbi.nlm.nih.gov/pubmed/37425044
http://dx.doi.org/10.1016/j.apsb.2023.05.016

Ejemplares similares